08:08 AM EDT, 09/17/2024 (MT Newswires) -- Cardinal Health ( CAH ) has been selected by Australia's Telix Pharmaceuticals as a commercial radiopharmaceutical distributor to supply Zircaix for the imaging of kidney cancer in the US, the companies said on Tuesday.

Financial terms weren't disclosed. The distribution agreement is subject to regulatory approval, according to the companies.

Price: 114.60, Change: +1.32, Percent Change: +1.17